Ohsu Knight Cancer Institute
Clinical trials sponsored by Ohsu Knight Cancer Institute, explained in plain language.
-
Genetic testing guides cancer treatment in new study
Disease control TerminatedThis study tested a precision medicine approach for people with advanced cancers like breast, ovarian, pancreatic, prostate, or sarcoma. Researchers used genetic and protein tests to track how the cancer changes and then a team of experts recommended personalized drugs. The goal …
Phase: PHASE2 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated May 17, 2026 05:47 UTC
-
Can phone apps and scanners spot skin cancer as well as a dermatologist?
Diagnosis TerminatedThis study looked at whether three portable imaging tools—MoleMapper, Visiomed, and confocal microscopy—can help find melanoma early. Researchers compared the devices' accuracy to a dermatologist's exam in 17 people with suspicious moles. The goal was to see if these tools could …
Phase: NA • Sponsor: OHSU Knight Cancer Institute • Aim: Diagnosis
Last updated May 15, 2026 11:56 UTC
-
AI-Powered home skin check could revolutionize cancer detection
Diagnosis TerminatedThis study tested whether an at-home artificial intelligence system called Sklip can help people safely check their own moles and skin spots for signs of cancer. The goal was to see if the system could accurately identify which spots need a biopsy, potentially reducing unnecessar…
Phase: NA • Sponsor: OHSU Knight Cancer Institute • Aim: Diagnosis
Last updated May 11, 2026 20:39 UTC
-
New MRI method aims to solve brain tumor treatment mystery
Diagnosis TerminatedThis study tested whether a special MRI using ferumoxytol (an iron-based dye) can help doctors tell if a brain tumor (glioblastoma) is truly shrinking from immunotherapy or just showing temporary swelling from treatment. About 52 patients were planned, but the study was stopped e…
Phase: PHASE2 • Sponsor: OHSU Knight Cancer Institute • Aim: Diagnosis
Last updated May 04, 2026 16:29 UTC